AMTZ sets up Centre for
A scientific facility - Centre for
Biomaterial Testing - has been developed in country’s first medical technology
manufacturing park- Andhra Pradesh Med Tech Zone (AMTZ) to help manufacturers
test their products and assist them to overcome deficiencies in their products,
thereby enhancing product value in the market.
The facility will help serve the purpose of
sterility evaluation, histopathology evaluation, physio-chemical evaluation,
accelerated aging and package validation in accordance with international
standards like ISO and ASTM to to address unmet clinical needs.
Accelerated aging is an artificial procedure
for establishing the lifespan or shelf life of a product in an expedited manner.
Data obtained from the study is based on conditions that simulate the effects of
aging on the materials.
The state-of-the-art laboratory which is
primarily intended for medical device industry for physio-chemical evaluation as
well as biological evaluation of samples can also serve industries like
chemical, polymer and pharmaceuticals to evaluate the characteristics of
materials using spectroscopic and imaging modalities like scanning electron
microscopy (SEM) and transmission electron microscopy (TEM).
AMTZ has also inked formal agreements to set
up scientific facilities like Centre for Electro-Magnetic Interference/ Electro-
Magnetic Compatibility (EMI/EMC) and Electrical Safety Testing (EST), Centre for
X-ray and CT Scan Tube Manufacturing, Centre for 3D Designing, Printing, Rapid
Prototyping & Centre for Gamma Irradiation.
AMTZ with in-house high investment scientific
facilities would help manufacturers reduce the cost of manufacturing by more
than 40 per cent to 50 per cent.
(http://pharmabiz.com , July 30, 2018 )
India, US move a step closer : Trade
Issues including Medical Devices.
India and the United States have moved a step closer in
resolving trade disputes, with India agreeing to accept some of the US' demands
on medical devices and electronics (IT), Hindustan Timesreports.
The two countries have discussed concessions on medical
devices, dairy and IT products, sources told the paper.
It is still unclear if there has been breakthrough on US
tariffs on steel and aluminium, and India's retaliatory tariffs, the report
The update on the trade issue is likely to be announced
before the 2+2 talks between India and the US, which will be held in September.
Commerce minister Suresh Prabhu spoke to US Trade
Representative Robert Lighthizer last week, the report said.
Moneycontrol could not independently verify the news. For
medical devices, India will probably cap the prices for some US products,
instead of imposing direct price controls, the report added.
India is likely to postpone the retaliatory tariffs, which
are due to start on August 4.